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Abstract
Background: Many materials are unsuitable for medical use because of poor biocompatibility. Recently, advances in the
high throughput synthesis of biomaterials has significantly increased the number of potential biomaterials, however current
biocompatibility analysis methods are slow and require histological analysis.
Methodology/Principal Findings: Here we develop rapid, non-invasive methods for in vivo quantification of the
inflammatory response to implanted biomaterials. Materials were placed subcutaneously in an array format and monitored
for host responses as per ISO 10993-6: 2001. Host cell activity in response to these materials was imaged kinetically, in vivo
using fluorescent whole animal imaging. Data captured using whole animal imaging displayed similar temporal trends in
cellular recruitment of phagocytes to the biomaterials compared to histological analysis.
Conclusions/Significance: Histological analysis similarity validates this technique as a novel, rapid approach for screening
biocompatibility of implanted materials. Through this technique there exists the possibility to rapidly screen large libraries
of polymers in vivo.
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Introduction
To our knowledge, there are no methods for in vivo visualization of
biocompatibility or inflammatory responses to implanted biomate-
rials. Traditionally, biocompatibility is determined via histology.
Histology allows for the determination of cell type and number near
the implant, including those belonging to the immune system.
However, histology is an endpoint measurement, allowing exami-
nation of only one time point per animal. Fluorescence imaging
represents a set of powerful techniques that have traditionally been
employed as a method for examining tumor models [1,2,3,4,5,6],
along with inflammation resulting from arthritis [7,8], pulmonary
inflammation [9,10], and transplant rejection models [11].
When a biomaterial is implanted, the healing response is initiated
bymonocytesandneutrophils,followedbypropagationoffibroblasts
and vascular endothelial cells [12]. Infiltration of inflammatory cells
can lead to such complications as: bio-instability of glucose sensors
[13]; overgrowth of encapsulated pancreatic islets for diabetes
therapy causing ischemia and, eventually, necrosis of the islets [14];
and constrictive fibrosis following silicone implants in mammary
augmentation [15]. Granulation tissue will then be formed and may
appearasearlyas3to5daysfollowingimplantation [12].Ingeneral,
granulation tissue will ultimately form a fibrous capsule surrounding
the implant [12].
Immunologicalresponsesaredynamicprocessesand, assuch,cell
type and population at the implant site change during the healing
process [16]. The sequence of local events following implantation is
generally regarded as the tissue response continuum in which each
individual event leads to the subsequent: injury progresses to acute
inflammation,which proceeds to chronic inflammation, followed by
granulation tissue formation, foreign body reaction and fibrous
encapsulation [16,17]. The presence of eosinophils and polymor-
phonuclear (PMN) cells typify acute inflammatory responses while
macrophages and fibroblasts signify the chronic form [18].
Neutrophils, together with monocytes and macrophages, release
cathepsins during the process of degranulation [19,20]. Cathepsins
are proteolytic enzymes responsible for digesting foreign material
[12].
Here, we describe the first methods for examining biomaterial
biocompatibility in vivo, using fluorescence reflectance screening.
The novelty of this technique lies in its ability to repeatedly analyze
foreign body responses in the same animal. The Macrophage
recruitment and protease enzyme activity, both of which serve as
markers of biocompatibility, were monitored in vivo, in real-time.
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10032We believe the methods developed here provide the first rapid
techniques for parallel determination of biomaterial biocompati-
bility in vivo in a non-invasive manner.
Methods
Molar Absorptivity
The absorbance of the two fluorophores, ProSense-680 and F4/
80 pan macrophage monoclonal antibody conjugated to FITC,
were monitored using UV/Vis absorbance spectroscopy over the
200 to 800 nm range. Solutions were diluted in 0.9% w/v NaCl
and housed in 1 cm path-length quartz cuvettes. Absorbances
were measured on a Cary 100 Bio UV/Vis Spectrophotometer.
Ethics Statement
The research protocol was approved by the local animal ethics
committees at Massachusetts Institute of Technology (Committee
on Animal Care) and Children’s Hospital Boston (Institutional
Animal Care and Use Committee) prior to initiation of the study.
Animals
8–12 week old male SKH1 mice were obtained from Charles
River Laboratories (Wilmington, MA). The mice were maintained
at the animal facilities of Massachusetts Institute of Technology,
accredited by the American Association of Laboratory Animal
care, and were housed under standard conditions with a 12-hour
light/dark cycle. Both water and food were provided ad libitum.
Injections
Injections were performed in accordance with ISO 10993-6:
2001. Prior to injection all materials were sterilized. Saline was
sterilized via 0.22 mm filtration; alginate was autoclaved for 20 min.
at 121uC; and polystyrene particles were washed in 70% ethanol
and re-suspended in sterile saline. The mice were anesthetized via
isoflurane inhalationat a concentration of 1–4% isoflurane/balance
O2 to minimize movement. Their backs were scrubbed with 70%
isopropylalcoholandtheanimalswereinjectedwith saline,2%-w/v
alginate (Protanal LF 10/60, FMC BioPolymer, Newark, DE,
having high guluronic acid composition (65–75%), mean molecular
weight of 180kDa), or 10%-w/v polystyrene beads (3.0 mm, Sigma
Aldrich, St. Louis, MO) in an array format on the mouse’s back.
Eight injections were made in each mouse in a random fashion to
establish position-dependent inflammatory responses. Injection
volumes ranged from 30–100 ml. All experiments were conducted
in quadruplicate for each imaging time-point. In addition, a set four
mice were imaged at every time-point and sacrificed at the 28 day
time-point.
Imaging
The following two imaging agents were co-injected into the tail
vein 24 hours before in vivo fluorescence imaging: ProSense-680
(VisEn Medical, Woburn, MA, excitation wavelength 680610 nm,
emission 700610 nm) [4] for imaging cathepsin activity, 2 nmol in
150 ml sterile PBS, and FITC-mAb F4/80 (Abcam, Cambridge,
MA, excitation wavelength 495 nm, emission 521 nm) for imaging
macrophage recruitment, 5 mg in 100 ml sterile PBS.
In vivo fluorescence imaging was performed with an IVIS-
Spectrum measurement system (Xenogen, Hopkinton, MA). The
animals were maintained under inhaled anesthesia using 1–4%
isoflurane in 100% oxygen at a flow rate of 2.5 L/min. A binning
of 868 and a field of view of 13.1 cm were used for imaging.
Exposure time and f/stop – the relative size of the opening of the
aperture - were optimized for each acquired image. Data were
acquired and analyzed using the manufacturer’s proprietary
Living Image 3.1 software. All images are presented in
fluorescence efficiency which is defined as the ratio of the collected
fluorescent intensity to an internal standard of incident intensity at
the selected imaging configuration. Regions of interest (ROIs)
were determined around the site of injection. ROI signal
intensities were calculated in fluorescent efficiency. Images were
obtained 1, 3, 7, 14, 21, and 28 days post-injection with four
replicates imaged at each time point. A separate set of four
replicates were imaged at all six time points.
Histology
Histology evaluated the severity of inflammation resulting
from the injected biomaterials. Mice were euthanized via CO2
asphyxiation and the injected biomaterial and surrounding tissue
were excised. The tissues were then fixed in 10% formalin,
embedded in paraffin, cut into 5 mm sections, and stained using
hematoxylin and eosin (H&E) for histological analysis by a
board certified pathologist. Fibrosis was rated on a scale where
a zero involved no fibrosis, a one indicated partial coverage with
one to two layers of fibrosis, a two is designated a thicker fibrotic
layer that nearly covered the implant, and a three denoted
concentric fibrotic coverage of the polymer. Both polymorphonu-
clear (PMN) cells and macrophages were rated on a scale where no
observed cells were indicated with a zero, scattered cells scored
a one, numerous cells clustering on the sides of the polymer scored
a two, and numerous cells surrounding the material resulted in a
three.
Statistical Analysis
The values of the histologic scores and the ROIs were averaged
and expressed as the mean 6 standard error of the mean.
Comparisons of values were performed by the Student’s
unpaired two-tailed t-test. P values less than 0.05 were con-
sidered significant.
Results
Linearity of Fluorescence Response to Dose
Concentration
Prior to quantifying responses in vivo, the linearity of the in vitro
fluorescence response to concentration of dye was assessed,
facilitated by the stationary superficially implanted target Fluores-
cence intensity F is proportional to the intensity of the excitation
beam that is absorbed by the system. That is,
F~K0 I0{I ðÞ ð1Þ
Where I0 is the intensity of the incident excitation beam and I is
the detected fluorescence intensity after traversing a length b of the
medium - in this case - the tissue of the animal. The constant K0
depends upon the quantum efficiency of the fluorescence process.
In order to relate F to the concentration c of the fluorescing
species, Beer’s law can be written in the form:
I
I0
~10{ebc ð2Þ
Where e is the molar absorptivity of the fluorescing molecules
and ebc is the absorbance. Inserting Beer’s law into equation 1, we
obtain:
F~K0I0 1{10{ebc 
: ð3Þ
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F~2:3K0ebcI0: ð4Þ
Assuming that I0 is constant, the fluorescence intensity is
linearly proportional to concentration at low absorbances. The
molar absorptivities were determined by UV-visible absorbance to
be 2.9060.04610
6 M
21 cm
21 and 2.3060.06610
5 M
21 cm
21
for ProSense-680 and FITC mAb-F4/80, respectively. With an
in vivo penetration depth for visible light of ,5m m i n
reflectance mode [1], the onset of nonlinear relations between
fluorescence and concentration would present at doses 5 and
2.5 times larger than those injected for FITC mAb-F4/80 and
ProSense-680, respectively, indicating the ability for relative
quantitative
analysis.
In Vivo Imaging of Cathepsin Activity and Macrophages
Mice were injected with alginate, polystyrene, or saline in an
array format (figure 1) in volumes of 30, 50, 70, and 100 ml.
Alginate is a bio-inert material used in a variety of biomedical
applications including encapsulation of insulin producing islets for
diabetes therapy [21,22,23,24], wound healing [25,26], implants
for cardiac remodeling following infarction [27,28]. In contrast,
Polystyrene exhibits high cellular adhesive properties, induces a
strong inflammatory response and was chosen as a positive
control. Polystyrene particles below 10 mm activate macrophages
and are easily phagocytosed [29], allowing them to serve as
positive controls. Saline serves as a negative control to assess the
background fluorescence level and aid in determination of the
detection limit. After injection, the mice were imaged at prescribed
time points for cathepsin activity and macrophages as shown in
figures 2a–c and 3a–c. Fluorescent regions of interest (ROIs) were
quantified for each image and are presented in figures 2d,e and
3d,e for cathepsin activity and macrophages recruitment.
Qualitatively, for saline, the cathepsin activity and macrophage
fluorescent signal appear to be very low with the exception of
cathepsin activity on day 7. For polystyrene, cathepsin activity
follows very similar trends wherein protease activity is detected on
day one, peaks at three weeks, and begins to decline at four weeks.
Recruitment of immune cells to alginate displays a different trend
than polystyrene in which cathepsin activity remains constant from
the first day to the fourth week. Macrophage recruitment for
polystyrene reached a plateau at day seven. Alginate arrived at this
plateau earlier, at the third day.
Quantitative performance criteria of methods are necessary in
determining whether this technique is suitable in analyzing
inflammatory responses. Detection limits are defined as the blank
plus three times the standard deviation of the blank and limit of
quantitation (LOQ) is ten times the standard deviation of the
blank. For macrophage detection, the detection limit is a
fluorescence efficiency of 9.4610
27 and the LOQ is a fluorescence
efficiency of 2.3610
26. ProSense-680 has a fluorescence efficiency
detection limit of 1.1610
25 and the fluorescence efficiency LOQ
is 1.8610
25. Quantification of fluorescence efficiency of both
cathepsin activity and macrophage recruitment is above the LOQ
as shown in figures 2 and 3. Cathepsin activity on the first day after
injection of polystyrene was not above the LOQ and therefore not
included in figure 2d. Macrophage recruitment on day one for
alginate and polystyrene were also below the LOQ and not
included in figure 3d and e.
Histology
Validation of the in vivo imaging technique for biocompatibility
described required histologic analysis subsequent to each imaging
Figure 1. Subcutaneous Injection arrays. Three array formats used for injecting saline and polymers subcutaneously in mice where A is 30 ml, B
is 50 ml, C is 70 ml, and D is 100 ml.
doi:10.1371/journal.pone.0010032.g001
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macrophages, and fibrosis. PMNs and macrophages were scored
on the basis of zero being normal cell populations, one being
scattered cells, two being numerous cells mostly populating the
sides of the polymer, and three being the most severe where
numerous cells surrounded the material. Quantified scores and
representative images are shown in figures 4 and 5, respectively.
Minimal PMNs are seen infiltrating the injection site for saline
whereas for alginate neutrophils completely surround the injection
site from day one to day 28. For polystyrene, neutrophils are
present the first day following injection, reaching a maximum
population at day 21 and subsequently decreasing.
Figure 2. Time evolution of cathepsin activity in response to injected materials fluorescently imaged. In vivo fluorescence imaging
using ProSense 680 for cathepsin activity at various time points for a) saline, b) polystyrene, and c) alginate. The scale bar ranges 0–6610
24 in
fluorescence efficiency. The quantified fluorescence efficiencies of cathepsin activities are shown for d) polystyrene and e) alginate as the mean with
standard deviation. Symbols represent data points and lines represent linear regressions.
doi:10.1371/journal.pone.0010032.g002
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(Fig. 4b). Slightly elevated levels of macrophages on days three and
seven likely resultfromtraumaofthe injury, notthe biocompatibility
of saline, and agrees with previous results [30]. A more pronounced
reaction occurs in response to polystyrene and alginate. Polystyrene
reaches a plateau seven days post-injection, while alginate levels out
at day three. The size of the polystyrene particles (3.0 mm) lends to
being easily phagocytosed, which can be seen in figure 5.
Fibrosis of the implants was also analyzed histologically in which a
score of zero denotes no fibrosis, one signifies partial coverage with
Figure 3. Time evolution of macrophage response to injected materials fluorescently imaged. In vivo fluorescence imaging of F4/80 pan
macrophage antibody at various time points for a) saline, b) polystyrene, and c) alginate. The scale bar ranges 0–1.5610
24 in fluorescence efficiency.
The quantified fluorescence efficiency of F4/80 pan macrophage responses are shown for d) polystyrene and e) alginate as the mean with standard
deviation. Symbols represent data points and lines represent linear regressions.
doi:10.1371/journal.pone.0010032.g003
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covering the implant, and three represents concentric fibrotic
coverage of the polymer. As seen in figure 4c, fibrosis for alginate
andpolystyrenegraduallyincreasesreachingamaximumatfourteen
days. This observation is in line with previous findings [31] in which
wound dressings of calcium alginate were grafted in porcine models
and found fibrosis to reach a maximum at 14 days. The slight
decrease in fibrosis scoring at day 28 might result from myofibro-
blasts contracting the wound as part of the healing process [32].
Discussion
Chemical signals responsible for invoking a response toward
implanted biomaterials may include proteins from invading
bacteria, clotting system peptides, complement products, and
cytokines that have been released by macrophages located in the
tissue near the implantation site [33]. Another group of chemical
attractants are chemokines which recruit neutrophils and mono-
cytes from the blood [34]. Macrophages derive from monocytes
[35]. Macrophages and monocytes can phagocytose cellular debris
and pathogens, and stimulate lymphocytes and other immune cells
to respond to the pathogen.
Typically for acute inflammation, neutrophil recruitment peaks
1–2 days after implantation and gradually resolves after 7–10 days
followed by macrophage migration at 1–2 days after injury [36].
Fibroblasts typically infiltrate at 2–3 days reaching a maximum
population at 3–4 days [36]. Both macrophages and fibroblasts
disperse after 5–9 days [36]. Chronic inflammation also begins
with recruitment of neutrophils [37]. Additionally, protease levels
are reported to be higher in chronic wounds [38]. Fibroblasts and
macrophages become numerous one to two weeks after injury and
diminish at six weeks [36,39]. Histologic analysis and in vivo
fluorescence imaging showed very similar trends in macrophage
recruitment and also in comparing cathepsin activity derived from
in vivo imaging to neutrophils evaluated via histology, suggesting
that a significant portion of the protease secreted derives from
neutrophils. Cathepsin may also derive from macrophages [40].
Christen et al. [11] have shown that ,75% of the prosense signal is
macrophage derived in transplant rejection. Early markers of
inflammation – macrophages and cathepsin activity – have been
chosen to assess biocompatibility of various polymers.
Traditionally, the local pathological effect of a material on living
tissue that is placed into an implant site is evaluated at both the
gross level and the microscopic level. Various biological param-
eters such as cellular responses and histopathological changes are
evaluated via ex vivo histology [17]. The throughput of histology
is typically on the order of days to several weeks and involves
steps such as fixation, embedding, processing, and staining. In vivo
Figure 4. Histological scores of materials subcutaneously injected. Histological scores of a) neutrophils, b) macrophages, and c) fibrosis
determined for tissue excised at various time points with injections of saline, polystyrene, and alginate. Values shown are means with standard
deviations.
doi:10.1371/journal.pone.0010032.g004
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anesthetization of the subject, thus greatly reducing the time
required to screen libraries of compounds. Recently, Sabaliauskas
et al. [41] have made advances in improving the throughput of
histology by automating and digitizing data acquisition. Gersner et
al. [42] have developed laser scanning cytometry methods to
quantify histological specimens, increasing the throughput of
analysis. Specimen preparation still remains a costly, labor-
intensive bottleneck in histology and, thus, in biocompatibility
screening.
Aside from quantitative detection limit and LOQ, comparison
of the dynamic ranges between histology and in vivo imaging is also
necessary in determining the abilities of fluorescence imaging in
assessing immune responses. In comparing histologic scores of
polystyrene with fluorescence imaging for cathepsin activity
(neutrophils), scores greater than 0.5 are above the detection
limit, meaning that the injection sites are distinguishable from the
background autofluorescence of the mouse. Histologic scores
above 1 appear to correlate to fluorescence efficiencies above the
LOQ for cathepsin activity (neutrophils). Comparing fluorescence
imaging to histologic scores for macrophages leads to the
conclusion that the detection limit and LOQ obtained for in vivo
imaging corresponds to a histologic score of 1.5, indicating the
possibility for false negatives in detecting macrophage infiltration
and the necessity for histologic analysis. However, the use of
amplification mechanisms such as use of fluorescent nanoparticles
avidly taken up by macrophages [4] will likely enhance sensitivity
drastically. Although this technique is semi-quantitative owing to
the poor depth penetration of visible light [1], in conjunction with
histology it possesses the ability to transform the rapidity with
which libraries of novel materials are assessed for biocompatibility.
The methods developedhereprovide for rapid, in vivo analysis of
several different materials simultaneously, thereby allowing for
rapid, kinetic analysis of the foreign body response to a number of
biomaterials, as well as eliminating labor intensive tissue processing
steps typically necessary for histology. We anticipate that in vivo
fluorescence imaging may therefore help address bottlenecks in
analyzing biocompatibility of polymers and aid in understanding
foreign body responses to biomaterials. In vivo fluorescence imaging
also holds the advantage of monitoring temporal immune cell
changes, thus eliminating mouse-to-mouse variations present when
making a static histologic assessment.
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